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Abstract
Background: Choice of appropriate MR pulse sequence is important for any research studies using imaging-
derived data. The aim of this study was to compare semiquantitative assessment of subchondral bone marrow
edema-like lesions and subchondral cysts using intermediate-weighted (IW) fat-suppressed (fs) spin echo and Dual
Echo Steady State (DESS) sequences on 3 T MRI.
Methods: Included were 201 subjects aged 35-65 with frequent knee pain. 3T MRI was performed with the same
sequence protocol as in the Osteoarthritis Initiative (OAI). In a primary reading subchondral bone marrow edema-
like lesions were assessed according to the WORMS system. Two hundred subregions with such lesions were
randomly chosen. The extent of subchondral bone marrow edema-like lesions was re-evaluated separately using
sagittal IW fs and DESS sequences according to WORMS. Lesion size and confidence of the differentiation between
subchondral bone marrow edema-like lesions and subchondral cysts located within or adjacent to them was rated
from 0 to 3. Wilcoxon signed-rank tests and chi-square statistics were used to examine differences between the
two sequences.
Results: Of 200 subchondral bone marrow edema-like lesions detected by IW fs sequence, 93 lesions (46.5%) were
not depicted by the DESS sequence. The IW fs sequence depicted subchondral bone marrow edema-like lesions to
a larger extent than DESS (p < 0.0001), and the opposite was true for subchondral cysts. Confidence scores for
differentiation of the two types of lesions were not significantly different between the two sequences.
Conclusions: In direct comparison the IW fs sequence depicts more subchondral bone marrow edema-like lesions and
better demonstrate the extent of their maximum size. The DESS sequence helps in the differentiation of subchondral
bone marrow edema-like lesions and subchondral cysts. The IW fs sequence should be used for determination of lesion
extent whenever the size of subchondral bone marrow edema-like lesions is the focus of attention.
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Subchondral bone marrow edema-like lesions (BML) are
defined as non-cystic areas of ill-delineated hyperinten-
sity on fluid-sensitive fast spin echo (FSE) fat suppressed
(fs) pulse sequences and of hypointensity on T1-weighted
(T1W) spin echo (SE) images [1]. They are one of the
features of osteoarthritis (OA) detected on MRI and are
observed regularly in conjunction with structural altera-
tions of adjacent cartilage. Higher prevalence and greater
volume of concomitant BMLs has been reported to asso-
ciated be with higher grades of cartilage loss [2].
As OA progresses, an increase in BML volume is seen
in the subchondral bone in many patients, and this is
positively correlated with an increase in cartilage loss in
the same region [2,3]. Subchondral cysts may be present
within or adjacent to a BML [4]. They are identified as
foci of markedly increased signal in the subchondral
bone with well delineated margins and no evidence of
internal marrow tissue or trabecular bone. Semiquantita-
tive assessment of subchondral BMLs and cysts is com-
monly performed on FSE sequences such as T2-weighted
(T2W), intermediate-weighted (IW) or proton density-
weighted (PDW) fs sequences [5] or short-tau inversion
recovery (STIR) sequence [6]. However, BMLs have also
been assessed on gradient recalled echo (GRE)-type
sequences such as Fast Low Angle Shot (FLASH) or
Spoiled Gradient Recalled (SPGR) [7] that are commonly
used for quantitative assessment of cartilage volume and
thickness due to their high contrast of cartilage to sub-
chondral bone [8]. There is an ongoing discussion
regarding the choice of MR pulse sequences that would
optimize BML assessment [9]. In light of this debate, a
head-to-head comparison of FSE and GRE sequences for
semiquantitative assessment of BMLs is needed to objec-
tively appreciate potential differences. The Osteoarthritis
Initiative (OAI) MRI protocol with sagittal IW fs and
DESS (Dual Echo Steady State, which is a T2-weighted
gradient echo sequence) sequences acquired at 3 T MRI
allows such a comparison.
The aim of our study was a comparison of semiquanti-
tative assessment of subchondral BMLs and subchondral
cysts using the DESS and IW fs sequences at 3 T MRI.
Due to lack of a definitive reference standard, this study
is primarily aimed at demonstrating how visualization of
subchondral BMLs and cysts differs by sequence and at
highlighting the strengths and weaknesses of each
sequence for assessment of those lesions.
Methods
Study subjects
Subjects included in the present study were participants
in the Joints On Glucosamine (JOG) cohort. The JOG
study is a 6-month double-blind randomized controlled
trial to examine the efficacy of oral glucosamine
supplementation. Two hundred and one participants,
aged 35 to 65, with mild to moderate chronic, frequent
knee pain (Western Ontario and McMaster Universities
(WOMAC) score ≥ 25 [10]) were recruited at the Univer-
sity of Pittsburgh, Pittsburgh, PA. Subjects were excluded
from JOG if they screened positive for rheumatoid arthri-
tis; had ankylosing spondylitis, psoriatic arthritis, chronic
reactive arthritis, or renal insufficiency that required
hemo- or peritoneal dialysis; were taking bisphospho-
nates or dietary supplements for knee pain in the 6
months prior to study entry; had a history of cancer
(except for non-melanoma skin cancer); had or planned
to have bilateral knee replacement surgery; or were
unable to walk without assistance. No BMLs of non-
degenerative origin (e.g. trauma) were found in this
study.
The baseline and follow-up MRI examinations of both
knees, when possible, of the 177 subjects who completed
the study were examined. Due to previous total knee
arthroplasty or the presence of radiographic end-stage
OA, eight participants had only one knee scanned, leav-
ing 346 knees that were included in the analyses.
Although the JOG Study itself was a longitudinal study,
the present study only involves a cross-sectional analysis
based on the MRI examinations taken at the baseline.
Institutional Review Board approval and all partici-
pants’ written informed consent were obtained for this
study.
MRI Acquisition
3 T MRI (Siemens Trio, Erlangen, Germany) was
a c q u i r e do nt h es a m eM R Is c a n n e rt h a ti su s e da tt h e
Pittsburgh site of the OAI. The identical pulse sequence
protocol used for the OAI was applied in the JOG study,
excluding the FLASH sequence and the Multi-Echo Spin
Echo T2 mapping sequence. Details of the full OAI pulse
sequence protocol and the sequence parameters have
been published [11]. The protocol included a sagittal 3D
DESS sequence with water excitation (WE) (slice thick-
ness = 0.7 mm, interslice gap = 0 mm, repetition time
(TR) = 16.3 ms, echo time (TE) = 4.7 ms, flip angle = 25°,
field of view (FOV) = 140 mm × 140 mm, matrix = 384 ×
307 pixels, echo train length = 1, number of slices = 35,
bandwidth = 185 Hz/pixel, number of excitations = 1,
anterior/posterior phase encoding axis, acquisition
time = 10 minutes 23 seconds), and the sagittal inter-
mediate-weighted (IW) fat-suppressed (fs) 2D turbo spin
echo (TSE) sequence (slice thickness = 3 mm, interslice
g a p=0m m ,T R=3 0m s ,T E=3 , 2 0 0m s ,f l i pa n g l e=
180°, FOV = 160 mm × 160 mm, matrix = 313 × 448 pix-
els, echo train length = 5, number of slices = 37, band-
width = 248 Hz/pixel, number of excitations = 1,
anterior/posterior phase encoding axis, acquisition
time = 4 minutes 42 seconds).
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One musculoskeletal radiologist (FWR) with 7 years
experience of standardized semiquantitative assessment
of knee OA, blinded to clinical data, read the baseline
MR images of all 346 knees using all 5 available
sequences. The MRI evaluation in JOG included the joint
features of subchondral BMLs, subchondral cysts, carti-
lage, meniscus, effusion and synovitis using the Whole
Organ Magnetic Resonance Imaging Score (WORMS)
method [12]. WORMS is a validated research tool for
semiquantitative assessment of knee OA. In WORMS,
subchondral BMLs are scored from 0 to 3 based on the
extent of subregional involvement (0 = none; 1 = < 25%
o ft h es u b r e g i o n ;2=2 5 - 5 0 % ;3=>5 0 % ,F i g u r e1 ,2 a ) .
Similarly, subchondral cysts are also scored from 0 to 3
based on the lesion extent in regard to subregional invol-
vement (0 = none; 1 = < 25% of the subregion; 2 = 25-
50%; 3 = > 50%, Figure 2b) at baseline. Thus, the
WORMS score for subchondral BMLs and cysts is a sum
of percentage of subregion for each type of lesion and
does not give information on the number of lesions. In
the following, we will use the term subchondral BML and
subchondral cyst interchangeably for “percentage of the
area occupied by BML and cyst within a subregion” as
defined in WORMS. Altogether 654 subregions exhibit-
ing subchondral BMLs were observed in 262 knees. Two
hundred subregions exhibiting subchondral BMLs from
63 knees of 42 subjects in the primary reading were ran-
domly chosen for the consequent direct sequence com-
parison. One hundred and ten of these 200 subregions
also exhibited subchondral cysts.
In a second consensus reading by two experienced mus-
culoskeletal radiologists (FWR, AG) with 7 and 9 years
experience in standardized semiquantitative MR assess-
ment of knee OA, these 200 subregions were re-evaluated
using the sagittal 3D DESS and sagittal IW fs TSE
sequences only. Readings for both sequences were per-
formed separately with a time interval of 4 weeks to avoid
recognition bias. All subregions were re-evaluated for
lesion size of subchondral BMLs and cysts. Further, confi-
dence of the differentiation between these two types of
lesions was rated on a 0-3 scale (0 = unable to differenti-
ate; 1 = doubtful differentiation; 2 = may be able to differ-
entiate with some confidence; 3 = able to differentiate
with definite confidence). Wilcoxon signed-rank tests for
paired comparisons of clustered data were used to exam-
ine if there were statistically significant differences
between the two sequences, and clustering by person was
controlled [13]. All analyses were performed using SAS®
software (Version 9.2 for Windows; SAS Institute, Cary, NC).
Results
Of the 177 participants who completed the study, mean
age at enrollment was 52.3 (SD ± 6.2). There were
slightly more men than women (53.7% men) and patients
were on average overweight (mean BMI 29.1 ± 4.1). Of
the 200 subregions assessed with BML scores > 0 at the
Figure 1 Regional subdivision of the articular surfaces of the
tibiofemoral joint of the knee. The femur and tibia are divided
into lateral (L) and medial (M) regions, with the trochlear groove of
the femur considered part of the M region. Region S represents the
portion of the tibia beneath the tibial spines. The femoral and tibial
surfaces are further subdivided into anterior (A), central (C) and
posterior (P) regions. Region A of the femur corresponds to the
patellofemoral articulation; region C the weight bearing surface and
region P the posterior convexity that articulates only in extreme
flexion. Region C of the tibial surface corresponds to the uncovered
portion between the anterior and posterior horns of the meniscus
centrally and the portion covered by the body of the meniscus
peripherally.
Figure 2 Schematic illustration of semiquantitative scoring
system for subchondral bone marrow edema-like lesions and
subchondral cysts using the Whole Organ Magnetic Resonance
Imaging Score (WORMS). a: Scoring of subchondral bone marrow
edema-like lesions. The score is based on the extent of regional
marrow involvement by areas of free water signal with ill-defined
margins. b: Scoring of subchondral cysts. The score is based on the
extent of focal bone loss through individual cysts (illustrated in the
central region) or multiple cysts (illustrated in the posterior region)
subchondrally.
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in the right knee; 81 (41%) were found in the medial,
24 (12%) in the lateral tibiofemoral compartments, and
94 (48%) were detected in the patellofemoral compart-
ments (Table 1).
The IW fs sequence demonstrated size of subchondral
BMLs as being larger in 186 (93.0%) subregions when
compared to the DESS (Wilcoxon signed-rank test, p <
0.0001) (Table 2). This includes presence of subchondral
B M L so nt h eI Wf ss e q u e n c ea n da b s e n c eo nt h eD E S S
sequence. These were depicted larger by one grade in
119 (59.5%), by two grades in 52 (26.0%) and by three
grades in 15 (7.5%) subregions (Figure 3). For subregions
in which subchondral BMLs were depicted in both
sequences, the corresponding numbers for one grade and
two grade differences (i.e. larger in IW fs sequence) were
64 (59.8%) and 29 (27.1%). Fourteen (7.0%) subregions
were scored with the same grade in both sequences. In
no case did the IW fs exhibit the lesions as being smaller
when compared to the DESS. Ninety three (46.5%) subre-
gions with subchondral BMLs on the IW fs sequence did
not exhibit any such lesions on the DESS.
In contrast, for subchondral cysts, the DESS sequence
demonstrated the lesions to a larger extent than the IW fs
sequence in 40 cases (36.4%) (Wilcoxon signed-rank test,
p < 0.0001) (Table 3). Seventy six lesions (69.1%) were
scored with the same grade in both sequences (Figure 4),
and in only one case did the IW fs sequence demonstrate
the lesion to a larger extent than the DESS.
The distribution of the confidence ratings for the differ-
entiation of subchondral BMLs and cysts varied between
the sequences (Table 4), but by the Wilcoxon sign-rank
test, the sequences were not different (p = 0.93). The con-
fidence score was higher in the IW fs sequence in 41
lesions (20.5%), higher in DESS sequence in 85 lesions
(42.5%), and the scores were the same in 74 (37%) lesions.
Discussion
Summarizing our results, we found that subchondral
BMLs were more conspicuous and appeared larger when
using the sagittal IW fs TSE sequence, compared with
the sagittal DESS sequence. Conversely, subchondral
cysts appeared larger when using the DESS sequence.
Confidence ratings for the differentiation of subchondral
BMLs and cysts were not significantly different between
the two sequences.
Choice of appropriate pulse sequences is a very impor-
tant issue in MRI-based OA research. As we have shown,
the extent of subchondral BMLs will be underestimated,
or lesions might be completely missed by using the DESS
sequence. Subchondral BMLs are an important feature of
knee OA that is associated with pain [14] and cartilage
damage [2]. Multiple publications have utilized MRI-
assessment of subchondral BMLs, with most of these
applying semiquantitative approaches [2,4,7,15] and others
applying quantitative methodology [16-18]. However some
of the results presented in these studies should be inter-
preted carefully, since GRE-type sequences that may not
fully depict subchondral BMLs were used [7].
GRE-type sequences, even with robust fat suppression
or water excitation, are notoriously insenstitive to bone
marrow abnormalities due to trabecular magnetic sus-
ceptibility of T2* effects, which may result in underesti-
mation of the size of subchondral BMLs [19,20]. Recent
studies have demonstrated that these sequences are also
less sensitive in the detection of subchondral BMLs when
u s i n gF S Es e q u e n c e sa st h er e f e r e n c es t a n d a r d[ 2 1 , 2 2 ] .
These results were summarized and published in a con-
sensus statement by Outcome Measures in Rheumatol-
ogy Clinical Trials (OMERACT) and Osteoarthritis
Research Society International (OARSI) in 2006 [5]. Our
results are in line with these previous publications and
further strengthen the case that GRE-type sequences are
inappropriate for assessment of subchondral BMLs.
Table 1 Distribution of non-cystic bone marrow lesions
according to their locations
Location* Frequency (Percent)
Tibiofemoral joint 105 (52.5)
Subspinous 27 (13.5)
Lateral femur (central and posterior) 8 (4.0)
Lateral tibia 16 (8.0)
Medial femur (central and posterior) 28 (14.0)
Medial tibia 26 (13.0)
Patellofemoral joint 95 (47.5)
Lateral femur (anterior) 24 (12.0)
Medial femur (anterior) 15 (7.5)
Lateral patella 34 (17.0)
Medial patella 22 (11.0)
* According to the Whole Organ Magnetic Resonance Imaging Score
(WORMS), the knee joint is classified into tibiofemoral joint (including
subspinous subregion, central and posterior, lateral and medial femoral
subregions and lateral and medial tibial subregions) and patellofemoral joint
(including anterior lateral and medial femoral subregions, and lateral and
medial patellar subregions).
Table 2 Comparison of the extent of non-cystic BMLs (n
= 200) as semiquantitatively evaluated using
intermediate-weighted (IW) fat-suppressed (fs) and Dual
Echo Steady-State (DESS) sequences
IW fs DESS
Score Frequency (%) Frequency (%)
0 0 (0) 93 (46.5)
1 67 (33.5) 100 (50.0)
2 84 (42.0) 7 (3.5)
3 49 (24.5) 0 (0)
*Overall, IW fs sequence demonstrated the lesions to a larger extent than
DESS sequence (Wilcoxon signed-rank test controlling for clustering by
person, p < 0.0001).
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fs sequences may also be used and may offer equivalent
diagnostic performance for subchondral BML evaluation
compared to non-enhanced PDw FSE sequences [16], but
administration of a contrast agent is not routine for assess-
ment of OA knees, except when synovitis evaluation is the
center of attention.
Although we focused on subchondral BMLs that are of
degenerative origin only, they can represent a variety of
pathologies [23]. Since this study demonstrated their
appearance may vary depending on the MRI pulse
sequence used, one should be cautious when evaluating
BMLs even if they are non-degenerative in origin.
Subchondral cysts are better delineated by the DESS
sequence. In this situation, the insensitivity of GRE-type
sequences to subchondral BMLs is actually advantageous
[5], and the borders between subchondral BMLs and
cysts are more clearly delineated than by FSE sequences.
The IW fs sequence usually delineates less clearly the
sclerotic rim of the cyst when compared to the DESS
sequence, and thus a peripheral portion of the cyst might
be attributed to be ill-defined on the IW fs sequence.
T h i sm a yb et h er e a s o nw h yt h ec y s t sa p p e a rl a r g e ro n
the DESS sequence.
Thus far, studies have shown no association between the
presence of subchondral cysts and pain in subjects with
knee OA [24,25], and thus clinical research efforts tend to
be more focused on subchondral BMLs, whose association
with pain has been clearly demonstrated [14,26]. Ideally,
all research protocols should include both a GRE-type
sequence and a FSE fs sequence [5], but if practical rea-
sons (e.g. funding issues) limit the number of sequences
t h a tc a nb ea c q u i r e di nag i v e ns t u d y ,F S Ef ss e q u e n c e s
should be acquired in preference to GRE-type sequences
whenever subchondral BMLs are the focus of study.
Limitations of the present study include a lack of refer-
ence standard. Thus, the true size of subchondral BMLs
was not assessed by either sequence. One might poten-
tially argue that an IW fs sequence overestimates the
extent of the lesion relative to the DESS sequence.
Although this cannot be ruled out completely, based
upon current knowledge, we believe it is more likely that
IW fs depicts the maximum extent of subchondral BMLs
[6]. Zanetti et al. showed that the location of ‘bone mar-
row edema-pattern signal alteration’ (which is the same
as the subchondral BML in our study) on one of the
Figure 3 61-year old woman with medial tibio-femoral knee osteoarthritis. a: Sagittal intermediate-weighted (IW) fat-suppressed image
depicts a grade 2 subchondral bone marrow edema-like lesion at the central medial tibial plateau that extends to the anterior subregion (long
white arrows show the approximate location of the ill-defined margin of the lesion). In addition, there is a grade 1 subchondral bone marrow
edema-like lesion at the posterior medial femur (short white arrows show the approximate location of the ill-defined margin of the lesion). b:
Sagittal Dual Echo Steady-State (DESS) image shows no bone marrow edema-like lesion in neither the femur nor the tibia.
Table 3 Comparison of the extent of cystic BMLs (n =
113) as semiquantitatively evaluated using intermediate-
weighted (IW) fat-suppressed (fs) and Dual Echo Steady-
State (DESS) sequences
IW fs DESS
Score Frequency (%) Frequency (%)
0 17 (15.5) 0
1 73 (66.4) 74 (67.3)
2 13 (11.8) 28 (25.5)
3 7 (6.4) 8 (7.3)
*Overall, DESS sequence demonstrated the lesions to a larger extent than IW
fs sequence (Wilcoxon signed-rank test controlling for clustering by person, p
< 0.0001).
Hayashi et al. BMC Musculoskeletal Disorders 2011, 12:198
http://www.biomedcentral.com/1471-2474/12/198
Page 5 of 8fluid-sensitive non-GRE type sequences (STIR) corre-
sponded to the area of bone marrow edema-like changes
as confirmed by histological analysis [6]. No study has
confirmed if the extent of subchondral BMLs as seen on
GRE-type sequences matched that seen on histological
examination. Another limitation that must be noted is
that the imaging evaluation occurs at only one time
point, and thus we are unable to comment on each
sequence’s sensitivity to change in a longitudinal study.
Lastly, we did not evaluate the state of hyaline cartilage
and their appearances in the two types of pulse sequences
because it was deemed outside the scope of the present
study. However, interested readers are directed to a
recently published article which compared semiquantita-
tive assessment of focal cartilage damage using the DESS
and IW fs sequences [27]. They demonstrated that the
IW fs sequence detected more and larger focal cartilage
defects than the DESS, but more intrachondral signal
changes were observed with the DESS.
Conclusions
Summarizing our findings, the maximum extent of sub-
chondral BMLs seems to be depicted on the IW fs
sequence when compared directly to the DESS. The
DESS sequence helps in the differentiation of subchon-
dral BMLs and cysts, as it depicts cysts as being larger
than on the IW fs sequence. Further, the DESS may show
only the cysts and not the ill-defined subchondral BMLs.
Both sequences appear to be complementary and, based
on our results, clear superiority of one sequence over the
other could not be demonstrated. However, if the main
f o c u so fa n ys t u d yi se v a l u a t i o no fs u b c h o n d r a lB M L s ,
assessment should be performed on FSE fs sequences
that depict these lesions to their maximum extent.
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